Assessing and Managing Disease Progression in Relapsing Forms of Multiple Sclerosis
A baseline predictor of 9-year disability worsening was the presence of optic nerve lesions; the 1-year Expanded Disability Status…
New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio (MS and NMOD information in this article)
Wednesday, Apr 7, 2021 Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type…
Stuart Schlossman
Protecting Myelin-producing Cells From Inflammation May Be Key to Treating MS
APRIL 2, 2021 BY MARTA FIGUEIREDO PHD Click HERE to Subscribe for the MS Beacon eNewsletter Prolonging a cellular…
Stuart Schlossman
Emerald Health Pharmaceuticals Starts Activities for Initiation of Phase 2 Clinical Study in Multiple Sclerosis
March 8, 2021 HP-101, a novel product candidate with a unique multi-modal mechanism of action, has demonstrated disease-modifying potential in…
Stuart Schlossman
BTK blockers make headway in multiple sclerosis
By targeting both arms of the immune system, not just B cells, brain-penetrant inhibitors of Bruton’s tyrosine kinase could improve…
Stuart Schlossman
LEARN about Bruton’s tyrosine kinase (BTK) inhibitors: a promising emerging treatment option for multiple sclerosis
Introduction Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) leading to demyelination and neurodegeneration.…
Stuart Schlossman
New research describes how the inflammation characteristic of multiple sclerosis affects neurons
Inflammation destroys the junctions between neurons, slowing information transfer With electrical signals zapping at speeds up to 288 km/h (180 mph),…
Stuart Schlossman
• Mouse Study Finds Potential Treatment for Myelin Repair for MS, Aging
A decline in the activity of the GPR17 gene is responsible for age-related brain deterioration caused by the loss of myelin, a…
Stuart Schlossman
Masitinib May Slow Disease Progression in Neurodegenerative Disorders
March 10, 2021 Treatment with masitinib was shown to prevent the amyloid-induced hemichannel-dependent mast cell activity in bone marrow-derived mast…
Stuart Schlossman
Kinin B1 Receptor messenger RNA (mRNA) Expression on Multiple Sclerosis Mononuclear Cells
Abstract Background: We have previously shown that the inducible kinin B(1) receptor is expressed on T lymphocytes during relapses and progression…
Stuart Schlossman
